This startup provides AI-powered image analysis tools for biotech companies to accelerate drug discovery. By automating and enhancing image analysis workflows, the platform enables faster identification of potential therapeutic candidates.
Funding
Funding not disclosed
Founders
Product
Problem
Biotech companies face bottlenecks in drug discovery due to the time-consuming and manual nature of microscopy image analysis. This slows down the identification of potential therapeutic candidates and delays the overall drug development process.
Solution
Fabric Bio offers an AI-powered platform designed to automate and accelerate microscopy image analysis for biotech companies. The platform enables users to design analysis pipelines, execute workflows, and extract insights at scale. By leveraging fully automated AI agents, Fabric Bio helps researchers identify potential therapeutic candidates more efficiently.
Target Audience
The primary target audience includes biotech companies and research institutions involved in drug discovery and development.
Features
- Fully automated AI agents for microscopy image analysis
- Design and execution of custom analysis pipelines
- Scalable workflow processing for large image datasets
- Rapid extraction of insights from complex biological images